Cancer Research Technology Ltd. (“CRT”), specialists in oncology-focused development and commercialisation, today announced the establishment of Cancer Research Technology Inc. (“CRT Inc.”), a US subsidiary based in Boston and the recruitment of Dr Larry Steranka as Managing Director.
